Offerings / Regulation CF / Fisher Wallace Laboratories, Inc.
Fisher Wallace Laboratories, Inc.
Regulation Crowdfunding offering on DealMaker Securities · Form C filed April 17, 2026 · Brooklyn, New York
Repeat issuerCommon stockEarly revenueCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on August 23, 2019, based in Brooklyn, NY, with 3 employees and $34,261 of revenue in its most recent fiscal year.
Offering terms
- Security
- Common Stock
- Maximum
- $4,398,747.72
- Price
- $11.30 per unit
- Pricing method
- Not stated
- Deadline
- July 31, 2026
- Oversubscriptions
- Accepted
- Intermediary
- DEALMAKER SECURITIES LLC
Broker-dealer, SEC file 008-70756 - Intermediary fee
- Up to 8.5%
- Intermediary equity
- None
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $34,261 | $47,412 |
| Cost of goods sold | $5,049 | $3,012 |
| Net income (loss) | -$1,447,538 | -$1,579,900 |
| Total assets | $144,634 | $154,382 |
| Cash and equivalents | $48,142 | $41,626 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $591,311 | $596,721 |
| Long-term debt | $693,612 | $925,582 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 3 employees. Offered in 64 states.